Mobile UPI  |   About UPI  |   UPI en Español  |   UPI Arabic  |   UPIU  |   My Account
Search:
Go

Teva's generic Lamisil approved

|
|
 
  
Published: July 3, 2007 at 10:07 AM

JERUSALEM, July 3 (UPI) -- Teva said Tuesday the U.S. Food and Drug Administration approved its generic formulation of Novartis' anti-fungal agent, Lamisil tablets.

Teva said it will immediately begin shipping its product.

The FDA's approval covers the company's abbreviated new drug application for 250 mg tablets of terbinafine, the active ingredient in Lamisil. In addition to Teva, the FDA approved generic versions of Lamisil tablets from several other manufacturers, including Apotex, Dr. Reddy's Laboratories and Mylan.

Annual U.S. sales for Lamisil were approximately $685 million for the 12 months ended March 31. The drug is indicated for treating onychomycosis, a fungal infection of fingernails or toenails.

© 2007 United Press International, Inc. All Rights Reserved. Any reproduction, republication, redistribution and/or modification of any UPI content is expressly prohibited without UPI's prior written consent.

Order reprints
  
Join the conversation
Most Popular Collections
The Chicago Auto Show The making of the Oscars Mercedes-Benz fashion week In New York
The Tibetan Moniam Festival in China The White House Science Fair Super Bowl XLVI ticker tape victory parade
Additional Health News Stories
1 of 21
President Obama Signs Smuggling Prevention Act at White House
View Caption
fark
Dude looks like a lady
All fifth graders who want to go see "Red Tails" please step forward. Whoa not so fast there girls...
If we timewarped back by 2000 years, what job would you be most qualified to do? No, you can't bring...
BAD: getting caught in a landslide while hiking. WORSE: getting struck by lightning while trying...
Weepy eyes, hot chix, Jersey Shore Ronnie and a guy with mini fishing reels stuck in his beard....
French roadbuilders find 21 German WWI soldiers...and 1 goat